THE DEAL, AT A GLANCE
2/4 reviewedBioWraptor
BioWraptor
BioWraptor develops protective wraps to keep fragile biological molecules stable at room temperature.
BioWraptor raised $1.5M Pre-Seed, announced 2026-11-12What it doesBioWraptor develops protective wraps to keep fragile biological molecules stable at room temperature.Source-grounded · automated review · Explore ↗
Checked 2026-11-12 · Review due 2026-11-19
Read supporting source ↗BioWraptor has engineered naturally derived…
Who is involvedBacked by Biomimicry InstituteFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedBioWraptor raised $1.5M Pre-Seed, announced 2026-11-12From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersThe funding will expand laboratory resources to support customer trials and bring the technology to market.Source-grounded · automated review · Explore ↗
Checked 2026-11-12 · Review due 2026-11-19
Read supporting source ↗The proceeds will expand laboratory…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
BioWraptor · Financing Record
Explore source-linked visual explanations for BioWraptor. Unsupported claims are withheld while source review continues.
Record 15910 · Recorded date: 2026-11-12
Explore company records →